...
Mask Group 47

Rodney J. Williams, MBA

Director and Chairman of Governance Committee

since April 2016

With over 20 years of medical technology and related healthcare experience, Rodney (Rod) J. Williams has demonstrated incredible agility and success in leading both large and small-cap companies through growth cycles while strengthening their product portfolio and boosting commercial planning competencies. Since August 1, 2022, he has been CEO of Neuro Event Labs, Inc., a global service provider of NeuroDx services for diagnosing and monitoring epilepsy seizures. Prior to this, Williams was on the board and was CEO and president of Pacement Inc., a service provider for cardiac remote monitoring for implantable devices. He held these positions from January 2017 to November 2021. Williams was also the Global Vice President of Portfolio and services with Align Technology, Inc, as well as an entrepreneur-in-residence with the private equity investment firm PTV Healthcare Capital. Before that, Williams was president and CEO of Heart Rhythm Society Consulting Services. He also served in senior executive positions with St. Jude Medical, GE Healthcare, Johnson and Johnson, and Bausch& Lomb. He also served in senior executive positions with St. Jude Medical, GE Healthcare, Johnson and Johnson, and Bausch & Lomb.

Williams earned both his MBA and Bachelor of Science degrees from the University of Southern California (USC) and attended the General Management Executive Leadership Program at The Wharton School of Business. While at USC, on a football scholarship, he gained NCAA Academic All-American honors and numerous academic awards as the TOP student-athlete. Williams was drafted into the National Football League in 1985.

Mask Group 47

Chris MacLeod, Director